We are delighted to share a collection of highly viewed papers in Section “Cancer Drug Development” that were published in Cancers (ISSN: 2072-6694) in the first half of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:

The list of relevant papers can be seen below:

“Current Progress and Future Perspectives of RNA-Based Cancer Vaccines: A 2025 Update”
by Matthias Magoola and Sarfaraz K. Niazi
Cancers 2025, 17(11), 1882; https://doi.org/10.3390/cancers17111882
Available online: https://www.mdpi.com/2072-6694/17/11/1882

“Opportunities and Challenges in Antibody–Drug Conjugates for Cancer Therapy: A New Era for Cancer Treatment”
by Idil Buyukgolcigezli, Ates Kutay Tenekeci and Ibrahim Halil Sahin
Cancers 2025, 17(6), 958; https://doi.org/10.3390/cancers17060958
Available online: https://www.mdpi.com/2072-6694/17/6/958

“Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications”
by Ante S. Lundberg, Cecile A. W. Geuijen, Sally Hill, Jeroen J. Lammerts van Bueren, Arianna Fumagalli, John de Kruif, Peter B. Silverman and Josep Tabernero
Cancers 2025, 17(10), 1665; https://doi.org/10.3390/cancers17101665
Available online: https://www.mdpi.com/2072-6694/17/10/1665

“Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges”
by Ashutosh Pareek, Deepanjali Kumar, Aaushi Pareek and Madan Mohan Gupta
Cancers 2025, 17(5), 878; https://doi.org/10.3390/cancers17050878
Available online: https://www.mdpi.com/2072-6694/17/5/878

“Advances in the Repurposing and Blood–Brain Barrier Penetrance of Drugs in Pediatric Brain Tumors”
by Julian S. Rechberger, Stephanie A. Toll, Subhasree Biswas, Hyo Bin You, William D. Chow, Nicholas Kendall, Pournima Navalkele and Soumen Khatua
Cancers 2025, 17(3), 439; https://doi.org/10.3390/cancers17030439
Available online: https://www.mdpi.com/2072-6694/17/3/439

“The Evolving Landscape in Multiple Myeloma: From Risk Stratification to T Cell-Directed Advanced Therapies”
by Carmen Besliu, Alina Daniela Tanase, Ionela Rotaru, Jose Espinoza, Laura Vidal, Martine Poelman, Manel Juan, Carlos Fernández de Larrea and Kamal S. Saini
Cancers 2025, 17(3), 525; https://doi.org/10.3390/cancers17030525
Available online: https://www.mdpi.com/2072-6694/17/3/525

Special Issues:

“Development of Biomarkers and Antineoplastic Drugs in Solid Tumors” Guest Editors: Dr. Rosa Falcone, Dr. Sofia Verkhovskaia and Dr. Michela Roberto Submission deadline: 31 March 2026	“Novel Drugs for Treating Gynecologic Cancers: 2nd Edition” Guest Editors: Prof. Dr. Tadahiro Shoji and Prof. Dr. Hiroaki Itamochi Submission deadline: 28 February 2026
“Advances in Drug Delivery for Cancer Therapy” Guest Editor: Dr. Ashakumary Lakshmikuttyamma Submission deadline: 31 January 2026	“Therapeutic Optimization of Anti-Tumor Drugs Based on Pharmacokinetics” Guest Editors: Dr. Paula Fresco and Dr. Joaquim António Faria Monteiro Submission deadline: 31 May 2026

 You can view and submit relevant papers to Cancers via the following link: https://www.mdpi.com/journal/cancers.

Cancers Editorial Office